Evidence map›Paper›PMID 41212211›Full record

ArticleDiabetologia2026

Bri2 BRICHOS domain inhibits IAPP amyloid formation and improves beta cell function in stem cell-derived islets under metabolic stress.

Jing Cen, Anja Ivis, Svitlana Vasylovska, Kina Adjieva, Robin S Lindsay, Gunilla T Westermark, Joey Lau

Abstract read
In one paragraph

Article in Diabetologia, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Jing CenDepartment of Medical Cell Biology, Uppsala University, Uppsala, Sweden.ORCID http://orcid.org/0000-0001-6014-3984
Anja IvisDepartment of Medical Cell Biology, Uppsala University, Uppsala, Sweden.ORCID http://orcid.org/0000-0001-5991-7137
Svitlana VasylovskaDepartment of Medical Cell Biology, Uppsala University, Uppsala, Sweden.ORCID http://orcid.org/0000-0003-0682-3449
Kina AdjievaDepartment of Medical Cell Biology, Uppsala University, Uppsala, Sweden.ORCID http://orcid.org/0009-0005-3729-3593
Robin S LindsayDepartment of Medical Cell Biology, Uppsala University, Uppsala, Sweden.ORCID http://orcid.org/0000-0001-7867-8653
Gunilla T WestermarkDepartment of Medical Cell Biology, Uppsala University, Uppsala, Sweden.ORCID http://orcid.org/0000-0003-1151-9986
Joey LauDepartment of Medical Cell Biology, Uppsala University, Uppsala, Sweden. Joey.Lau@mcb.uu.se.ORCID http://orcid.org/0000-0002-8302-3253

Funding

Novo Nordisk NNF24OC0092419
6 · The paper itself

Abstract

aims/hypothesisAccumulation of islet amyloid polypeptide (IAPP) and amyloid formation is associated with beta cell dysfunction and cell death in human islets and may also contribute to graft failure post stem cell-derived islet (SC-islet) transplantation. The BRICHOS domain, a secretory peptide proteolysed from the Bri2 protein, possesses chaperone activity and has been shown to inhibit fibril formation of amyloid β-peptide in the brain and IAPP in human islets. In this study, we aimed to evaluate amyloid formation in SC-islets in vitro, as well as assess the role of Bri2 BRICHOS on amyloid formation and beta cell function.

methodsHuman SC-islets were used as an in vitro model to explore the accelerated amyloid formation and to investigate the role of Bri2 BRICHOS via adenovirus-transduced overexpression. SC-islets were cultured under normal glucose conditions or metabolic stress-like conditions. Subsequently, amyloid formation was determined by staining with the amyloid-specific ligand pentameric formyl thiophene acetic acid and transmission electron microscopy. Beta cell function was assessed by static glucose-stimulated insulin secretion and insulin content. The presence of relevant proteins was evaluated by immunostaining and confocal microscopy. The mRNA expression profile of genes of interest was evaluated by qRT-PCR.

resultsWe showed that IAPP is colocalised with insulin in SC-islet beta cells and, like human islets, SC-islets can develop amyloid under metabolic stress in vitro. Amyloid formation was increased and beta cell function was impaired in SC-islets under metabolic stress and overexpression of the Bri2 BRICHOS domain in SC-islets effectively prevented amyloid formation and partially protected beta cell function. The accentuated endogenous gene expression of ITM2B, ADAM10 and IAPP in SC-islets under the same glucose-induced metabolic stress condition was not affected by the overexpression of the Bri2 BRICHOS domain. CONCLUSIONS/

interpretationOur findings suggest that the molecular chaperone Bri2 colocalises with IAPP and insulin in SC-islet beta cells. The folding assistance has been ascribed to the BRICHOS domain in Bri2 and viral overexpression of the BRICHOS domain can prevent the formation of cytotoxic IAPP amyloid and improve beta cell function in SC-islets exposed to metabolic stress. A comprehensive analysis of SC-islet functionality excludes beta cell impairment as a cause for amyloid reduction but supports the protection against IAPP amyloid.

Indexed as

AmyloidInsulin-Secreting CellsIslet Amyloid PolypeptideIslets of LangerhansAdaptor Proteins, Signal TransducingCells, CulturedHumansInsulinStress, PhysiologicalAdaptor Proteins, Signal TransducingAmyloidInsulinIslet Amyloid PolypeptideITM2B protein, humanBRICHOSDiabetesIAPPIslet amyloidSC-isletsStem cell-derived islets

Identifiers

PMID41212211
PMCPMC12779682

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.